RecruitingPhase 3NCT04528082
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Studying Behçet disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amgen
- Principal Investigator
- MDAmgen
- Intervention
- Apremilast(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2021 – 2030
Study locations (27)
- Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron, France
- Hopital Necker Enfants Malades, Paris, France
- Hopital Robert Debre, Paris, France
- Agia Sofia Children Hospital, Athens, Greece
- Attikon University General Hospital, Athens, Greece
- General Hospital of Thessaloniki Ippokrateio, Thessaloniki, Greece
- Meir Medical Center, Kfar Saba, Israel
- Ospedale Santissima Annunziata, Chieti, Italy
- IRCCS Istituto Giannina Gaslini, Genova, Italy
- Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini, Milan, Italy
- IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Italy
- Hospital Universitario Virgen del Rocio, Seville, Andalusia, Spain
- Hospital Universitari Vall d Hebron, Barcelona, Catalonia, Spain
- Hospital Sant Joan de Deu, Esplugues de Llobregat, Catalonia, Spain
- Hospital Universitari i Politecnic La Fe, Valencia, Valencia, Spain
- +12 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04528082 on ClinicalTrials.govOther trials for Behçet disease
Additional recruiting or active studies for the same condition.